IL-1 beta promotes A549 cell migration via MAPKs/AP-1- and NF-kappaB-dependent matrix metalloproteinase-9 expression

Area of Science:

• Molecular Biology
• Cell Biology
• Immunology

Background:

• Matrix metalloproteinases (MMPs), particularly MMP-9, are implicated in airway injury and remodeling.
• Interleukin-1 beta (IL-1 beta) is a key cytokine that induces MMP-9 expression.
• The precise mechanisms of IL-1 beta-induced MMP-9 expression and cell migration in A549 cells were not fully understood.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying IL-1 beta-induced MMP-9 gene expression and cell migration in human A549 cells.
• To investigate the roles of mitogen-activated protein kinases (MAPKs) and nuclear factor-kappaB (NF-kappaB) signaling pathways.

Main Methods:

• Zymography, RT-PCR, and Western blotting were used to assess MMP-9 expression.
• Small interfering RNA (siRNA) was employed to knock down specific MAPK pathway components (MEK1, p42, p38, JNK2).
• Reporter assays with wild-type and mutated MMP-9 promoter constructs, alongside NF-kappaB translocation studies, were performed.

Main Results:

• IL-1 beta induced MMP-9 expression and cell migration in A549 cells.
• MAPK pathways (p42/p44 MAPK, p38 MAPK, JNK1/2) and NF-kappaB activation were essential for IL-1 beta-induced MMP-9 expression.
• NF-kappaB translocation and I kappaB alpha degradation were observed following IL-1 beta stimulation.
• IL-1 beta-induced c-Jun phosphorylation was mediated by MAPK signaling.
• NF-kappaB was required for IL-1 beta-stimulated MMP-9 promoter activity.
• Inhibition of MAPKs, NF-kappaB, or MMPs attenuated IL-1 beta-induced cell migration.

Conclusions:

• Activation of p42/p44 MAPK, p38 MAPK, JNK1/2, NF-kappaB, and AP-1 are critical for IL-1 beta-induced MMP-9 gene expression in A549 cells.
• These signaling pathways are also essential for the IL-1 beta-driven cell migration.
• Understanding these mechanisms provides insights into airway inflammation and remodeling processes.